Pre-Conference Day

Join Roche for a high-impact workshop focused on the innovations and partnerships driving the next era of companion diagnostics. This is your opportunity to gain critical insights and connect with industry leaders. 

Key Takeaways & Session Focus:  

• Commercial Strategy & Global Collaboration: Explore best practices in CDx commercialisation, Dive deep into Diagnostic Partnership Across the Globe, featuring insights into affiliate partnering and a focused round table discussion. 
• Cutting-Edge Innovation: Explore the latest advancements across three pivotal areas: 

1. Digital Pathology: Featuring innovations in Digital Pathology, TROP2, and MPX 
2. Neurology: Discover the capabilities of the Neuro Toolkit 
3.  Sequencing: Learn about the SBX platform and other key innovations 

• Expert Panel: Conclude with an insightful Partnership Fireside Chat and Q&A session featuring a panel of leading experts. 

Don't miss out on this session packed with valuable content: the essential guide to commercialisation, global strategy, and breakthrough technology in precision medicine. 

Building a New Foundation for Clinical Development with Precision Diagnostics & Molecular Insights 

Advances in molecular diagnostics are redefining how clinical trials are designed and executed. This session will explore how Treatment on Molecular Residual Disease Result (TOMR) can unlock new approaches to development across  disease stages, with a focus on translating MRD insights into actionable clinical strategies. 

• Shape the future of TOMR-driven development through interactive discussion and feedback 
• Explore innovative trial designs and treatment paradigms in early-stage (adjuvant) settings 
• Examine how MRD can accelerate efficacy readouts in late-stage and metastatic programs 
• Workshop near-term clinical opportunities across indications and therapeutic modalities 

Engage in a collaborative session focused on practical application, ideation, and peer exchange with Team Natera. 

Pioneering Precision Medicine: A Hybrid Future for CDx

In this engager we explore how a groundbreaking industry collaboration is rethinking current CDx approaches through a hybrid model designed for rapid scalability and access to precision medicine.

Attendee will:

• Discover SOPHiA GENETICS’ and Myriad Genetics’ first-of-its-kind CDx partnership model to unlock scale, regulatory compliance, and access to precision diagnostics and therapies
• Gain insights into what a co-development strategy for CTA and CDx looks like in practice and how it enables simultaneous development and deployment at a central lab
• Understand how Pharma-Diagnostics collaborations can support late-stage clinical development through commercialisation

Addressing Your Biggest Challenges in Biomarker-Driven Drug Development

In this exciting session, hear directly from precision medicine leaders about the biggest challenges facing their drug development and companion diagnostic programs today. Attendees will have the opportunity to:

• Discuss key industry issues at table breakout sessions
• Share insights and best practices with the larger group
• Enjoy drinks and appetizers while networking in an engaging discussion format